SBI Securities’s LAVA Therapeutics LVTX Stock Holding History

SBI Securities’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300	Closed	-$468	–	4142
2025 Q3	$468	Hold	300	–	–	﹤0.01%	2995
2025 Q2	$396	Hold	300	–	–	﹤0.01%	3058
2025 Q1	$381	Hold	300	–	–	﹤0.01%	2975
2024 Q4	$285	Buy	+300	New	+$471	﹤0.01%	3108

SBI Securities's LVTX Position: Q4 2025 in Review

SBI Securities sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 300 shares — an estimated $468 sold.

SBI Securities first reported a position in LVTX in Q4 2024 and held it in 4 quarters. The position peaked at $468 in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

SBI Securities reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 300 LAVA Therapeutics shares in Q4 2025, an estimated $468.
SBI Securities first reported a position in LAVA Therapeutics in Q4 2024 and held it in 4 quarters.
SBI Securities's LAVA Therapeutics position peaked at $468 in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.